DaxibotulinimtoxinA for Treatment of Platysmal Neck Bands - Trial NCT06225492
Access comprehensive clinical trial information for NCT06225492 through Pure Global AI's free database. This Phase 4 trial is sponsored by Main Line Center for Laser Surgery and is currently Recruiting. The study focuses on Aging. Target enrollment is 20 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Main Line Center for Laser Surgery
Timeline & Enrollment
Phase 4
Jan 01, 2024
Jan 01, 2026
Primary Outcome
Effectiveness of DaxibotulinumtoxinA for platysmal neck bands measured on Platysmal Neck Banding Scale
Summary
This study seeks to evaluate the effectiveness and duration of action of DaxibotulinumtoxinA
 for neck rejuvenation through treatment of platysmal bands. This study will consist of one
 treatment visit with subjects being randomized to receiving 15 or 20 units of
 DaxibotulinumtoxinA per platysmal band. Subjects will return for 5 follow-up visits at 8, 12,
 16, 20, and 24 weeks for evaluation.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06225492
Non-Device Trial